Clonazepam
- Molecular formula
- C15H10ClFN2O3
- CAS Number
- 1622-61-3
- IUPAC Name
- 7-chloro-5-(2-fluorophenyl)-1-(2-hydroxyethyl)-3H-1,4-benzodiazepin-2-one
- Molecular Weight
- 315.72g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.3100g/cm3
- Synonyms
- 20971-53-3
Identification
Interesting Facts about 7-chloro-5-(2-fluorophenyl)-1-(2-hydroxyethyl)-3H-1,4-benzodiazepin-2-one
The compound known as 7-chloro-5-(2-fluorophenyl)-1-(2-hydroxyethyl)-3H-1,4-benzodiazepin-2-one is a fascinating member of the benzodiazepine family, often recognized for its unique properties and potential applications in medicine.
Key Features
- Mechanism of Action: This compound exhibits its effects primarily through interaction with the GABAA receptor, enhancing the inhibitory effects of GABA neurotransmitters. This mechanism is crucial for its anxiolytic and sedative properties.
- Chemical Modifications: The presence of a chlorine atom and a fluorophenyl group introduces significant alterations in its biological activity compared to other benzodiazepines. Such modifications are often designed to enhance potency and selectivity.
- Hydroxyethyl Group: The addition of a hydroxyethyl substituent is noteworthy as it may contribute to improved pharmacokinetic properties, such as solubility and distribution, which are vital for therapeutic efficacy.
Potential Applications
This compound's characteristics make it a subject of interest in pharmacological research, particularly for its potential use in treating:
- Anxiety disorders
- Insomnia
- Seizure disorders
Research and Development
Observations have indicated that compounds like 7-chloro-5-(2-fluorophenyl)-1-(2-hydroxyethyl)-3H-1,4-benzodiazepin-2-one can also serve as scaffolds for drug development. The ability to modify different functional groups allows chemists to design derivatives that may have improved efficacy or reduced side effects.
Overall, this compound exemplifies the intricate balance between chemical structure and biological function, embodying the ongoing evolution of benzodiazepine-based therapies. Ongoing studies will likely unravel more about its full therapeutic potential.